[1]
Dalyanoglu, H., Mehdiani, A., Minol, J.P., Sipahi, N.F., Aubin, H., Boeken, U., Müller, A., Makimoto, H., Lichtenberg, A. and Korbmacher, B. 2018. Conversion of Atrial Fibrillation after Cardiosurgical Procedures by Vernakalant® as an Atrial Repolarization Delaying Agent (ARDA). The Heart Surgery Forum. 21, 3 (May 2018), E201-E208. DOI:https://doi.org/10.1532/hsf.1970.